Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium
Conclusion: Although TKIs are used for long-term CML treatment, physicians sometimes recommend interruptions/discontinuations. In this study, interruptions/discontinuations were mainly caused by side effects or intolerance, rather than TFR attempts.Acta Haematol
Source: Acta Haematologica - Category: Hematology Source Type: research
More News: Belgium Health | Chronic Leukemia | Chronic Myeloid Leukaemia | Clinical Trials | Gleevec | Hematology | Leukemia | Nilotinib | Study | Tasigna